Chemical Phosphoproteomics Sheds New Light on the Targets and Modes of Action of AKT Inhibitors
- 23 March 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 16 (4) , 631-641
Abstract
Due to its important roles in oncogenic signaling, AKT has been subjected to extensive drug discovery efforts leading to small molecule inhibitors investigated in advanced clinical trials. To better understand how these drugs exert their therapeutic effects at the molecular level, we combined chemoproteomic target affinity profiling using kinobeads and phosphoproteomics to analyze the five clinical AKT inhibitors AZD5363 (Capivasertib), GSK2110183 (Afuresertib), GSK690693, Ipatasertib, and MK-2206 in BT-474 breast cancer cells. Kinobead profiling identified between four and 29 nM targets for these compounds and showed that AKT1 and AKT2 were the only common targets. Similarly, measuring the response of the phosphoproteome to the same inhibitors identified ∼1700 regulated phosphorylation sites, 276 of which were perturbed by all five compounds. This analysis expanded the known AKT signaling network by 119 phosphoproteins that may represent direct or indirect targets of AKT. Within this new network, 41 regulated phosphorylation sites harbor the AKT substrate motif, and recombinant kinase assays validated 16 as novel AKT substrates. These included CEP170 and FAM83H, suggesting a regulatory function of AKT in mitosis and cytoskeleton organization. In addition, a specific phosphorylation pattern on the ULK1-FIP200-ATG13-VAPB complex was found to determine the active state of ULK1, leading to elevated autophagy in response to AKT inhibition.Keywords
Funding Information
- Deutschen Konsortium f?r Translationale Krebsforschung
This publication has 52 references indexed in Scilit:
- Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 PhosphorylationScience, 2012
- Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal deathProceedings of the National Academy of Sciences, 2012
- A Mosaic Activating Mutation inAKT1Associated with the Proteus SyndromeNew England Journal of Medicine, 2011
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and ActivityCancer Cell, 2011
- In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKTCancer Research, 2009
- Akt-dependent and -independent mechanisms of mTOR regulation in cancerCellular Signalling, 2009
- Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric InhibitionPLOS Biology, 2009
- Akt regulates centrosome migration and spindle orientation in the early Drosophila melanogaster embryoJournal of Cell Biology, 2008
- Loss of Akt1 Leads to Severe Atherosclerosis and Occlusive Coronary Artery DiseaseCell Metabolism, 2007
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007